Selecting an oral anticoagulant for patients with nonvalvular atrial fibrillation View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2015-01

AUTHORS

Carlos J. Gonzalez Quesada, Robert P. Giugliano

ABSTRACT

While the use of warfarin has been the cornerstone of thromboembolism prevention in patients with atrial fibrillation (AF), its limitations have led to the introduction of a new generation of direct-acting oral anticoagulants. Evidence from large phase III clinical trials, observational studies and pharmacokinetic analyses can guide clinicians to select the most effective and safest form of anticoagulation for patients with nonvalvular AF. This manuscript describes the main pharmacologic, clinical and epidemiological characteristics of each new oral anticoagulant and their use in selected clinical scenarios, including patients with: advanced age; at low or high risk of stroke; potential drug-drug interactions; on concomitant antiplatelet therapy; at high risk for acute coronary syndrome; with recent gastrointestinal bleeding; with renal impairment; and with hepatic dysfunction. More... »

PAGES

129-138

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11239-014-1148-4

DOI

http://dx.doi.org/10.1007/s11239-014-1148-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1003113173

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25416142


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acute Coronary Syndrome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Oral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anticoagulants", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Atrial Fibrillation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clinical Trials, Phase III as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Interactions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gastrointestinal Hemorrhage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stroke", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Brigham and Women's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.62560.37", 
          "name": [
            "Department of Medicine, Brigham and Women\u2019s Hospital, 75 Francis St, 02115, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gonzalez Quesada", 
        "givenName": "Carlos J.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Brigham and Women's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.62560.37", 
          "name": [
            "Division of Cardiovascular Medicine, TIMI Study Group, Brigham and Women\u2019s Hospital, 350 Longwood Ave. 1st Floor Offices, 02115, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Giugliano", 
        "givenName": "Robert P.", 
        "id": "sg:person.0702207604.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702207604.00"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1093/europace/eut083", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011686963"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1107039", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018510213"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0905561", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018974880"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1310907", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023447903"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2014.03.022", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037324913"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1007432", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038815600"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1009638", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051578846"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehs253", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052629170"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(13)62343-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053051165"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-146-12-200706190-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073709095"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-01", 
    "datePublishedReg": "2015-01-01", 
    "description": "While the use of warfarin has been the cornerstone of thromboembolism prevention in patients with atrial fibrillation (AF), its limitations have led to the introduction of a new generation of direct-acting oral anticoagulants. Evidence from large phase III clinical trials, observational studies and pharmacokinetic analyses can guide clinicians to select the most effective and safest form of anticoagulation for patients with nonvalvular AF. This manuscript describes the main pharmacologic, clinical and epidemiological characteristics of each new oral anticoagulant and their use in selected clinical scenarios, including patients with: advanced age; at low or high risk of stroke; potential drug-drug interactions; on concomitant antiplatelet therapy; at high risk for acute coronary syndrome; with recent gastrointestinal bleeding; with renal impairment; and with hepatic dysfunction. ", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11239-014-1148-4", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1113719", 
        "issn": [
          "0929-5305", 
          "1573-742X"
        ], 
        "name": "Journal of Thrombosis and Thrombolysis", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "39"
      }
    ], 
    "name": "Selecting an oral anticoagulant for patients with nonvalvular atrial fibrillation", 
    "pagination": "129-138", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "0ed44acaa93949e127e802384aff805e1f8e1430dfd9050667cfd8e0e67b807d"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25416142"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9502018"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11239-014-1148-4"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1003113173"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11239-014-1148-4", 
      "https://app.dimensions.ai/details/publication/pub.1003113173"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:03", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8663_00000520.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs11239-014-1148-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11239-014-1148-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11239-014-1148-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11239-014-1148-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11239-014-1148-4'


 

This table displays all metadata directly associated to this object as RDF triples.

150 TRIPLES      21 PREDICATES      50 URIs      32 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11239-014-1148-4 schema:about N00413050f937487fa8a5051b884ab585
2 N1ec55ffde7934a02b3b3d6762f2b7066
3 N3137d138e2de40ae8640b4c9f8aa810f
4 N50deb7e2ec1f4602a30fb73218a5b7f9
5 N5962dd446d0a44cc9ad3ddf6dabe4dc3
6 N5ba76736dbe74ff8a108be46f30d6d50
7 N643411f2882c405ca23a252140618781
8 Na89fa2ce93b54013952199b7d4bb94e8
9 Nbe0bf36a322347c4b1edce7690bf5f48
10 Nc6b6d081ee054abf8071ca5fc299bcd7
11 Ncb730f55db9a4e578517679cac6eae47
12 anzsrc-for:11
13 anzsrc-for:1102
14 schema:author N475de2f6e5a344de8dd23b98d54eb61c
15 schema:citation https://doi.org/10.1016/j.jacc.2014.03.022
16 https://doi.org/10.1016/s0140-6736(13)62343-0
17 https://doi.org/10.1056/nejmoa0905561
18 https://doi.org/10.1056/nejmoa1007432
19 https://doi.org/10.1056/nejmoa1009638
20 https://doi.org/10.1056/nejmoa1107039
21 https://doi.org/10.1056/nejmoa1310907
22 https://doi.org/10.1093/eurheartj/ehs253
23 https://doi.org/10.1093/europace/eut083
24 https://doi.org/10.7326/0003-4819-146-12-200706190-00007
25 schema:datePublished 2015-01
26 schema:datePublishedReg 2015-01-01
27 schema:description While the use of warfarin has been the cornerstone of thromboembolism prevention in patients with atrial fibrillation (AF), its limitations have led to the introduction of a new generation of direct-acting oral anticoagulants. Evidence from large phase III clinical trials, observational studies and pharmacokinetic analyses can guide clinicians to select the most effective and safest form of anticoagulation for patients with nonvalvular AF. This manuscript describes the main pharmacologic, clinical and epidemiological characteristics of each new oral anticoagulant and their use in selected clinical scenarios, including patients with: advanced age; at low or high risk of stroke; potential drug-drug interactions; on concomitant antiplatelet therapy; at high risk for acute coronary syndrome; with recent gastrointestinal bleeding; with renal impairment; and with hepatic dysfunction.
28 schema:genre research_article
29 schema:inLanguage en
30 schema:isAccessibleForFree false
31 schema:isPartOf N0359c41429d24f8cb0c1280d57dc7294
32 N44b0b8b1f40041eab86d9b5344cfe89c
33 sg:journal.1113719
34 schema:name Selecting an oral anticoagulant for patients with nonvalvular atrial fibrillation
35 schema:pagination 129-138
36 schema:productId N185f2dde53ef40589257de7087b97157
37 N2596f0e3fcf246e6a6f17d0bc2c7a222
38 Nbf0239847e7747c09341fbd250d02aa3
39 Nc1ad978206424189be68cc9b0f1fa9c8
40 Nd77d384d66a14bf4b7bd8478d6b157e5
41 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003113173
42 https://doi.org/10.1007/s11239-014-1148-4
43 schema:sdDatePublished 2019-04-10T15:03
44 schema:sdLicense https://scigraph.springernature.com/explorer/license/
45 schema:sdPublisher N69f4dc9c366444ccb1da5fbcddfb40b7
46 schema:url http://link.springer.com/10.1007%2Fs11239-014-1148-4
47 sgo:license sg:explorer/license/
48 sgo:sdDataset articles
49 rdf:type schema:ScholarlyArticle
50 N00413050f937487fa8a5051b884ab585 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
51 schema:name Female
52 rdf:type schema:DefinedTerm
53 N0359c41429d24f8cb0c1280d57dc7294 schema:issueNumber 1
54 rdf:type schema:PublicationIssue
55 N185f2dde53ef40589257de7087b97157 schema:name dimensions_id
56 schema:value pub.1003113173
57 rdf:type schema:PropertyValue
58 N1ec55ffde7934a02b3b3d6762f2b7066 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
59 schema:name Drug Interactions
60 rdf:type schema:DefinedTerm
61 N2596f0e3fcf246e6a6f17d0bc2c7a222 schema:name nlm_unique_id
62 schema:value 9502018
63 rdf:type schema:PropertyValue
64 N3137d138e2de40ae8640b4c9f8aa810f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Humans
66 rdf:type schema:DefinedTerm
67 N44b0b8b1f40041eab86d9b5344cfe89c schema:volumeNumber 39
68 rdf:type schema:PublicationVolume
69 N475de2f6e5a344de8dd23b98d54eb61c rdf:first N68ffadc509754cebb295d177aa0fd5c3
70 rdf:rest N8521bb898c30409f873825ea6bd5b605
71 N50deb7e2ec1f4602a30fb73218a5b7f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Male
73 rdf:type schema:DefinedTerm
74 N5962dd446d0a44cc9ad3ddf6dabe4dc3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Administration, Oral
76 rdf:type schema:DefinedTerm
77 N5ba76736dbe74ff8a108be46f30d6d50 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Clinical Trials, Phase III as Topic
79 rdf:type schema:DefinedTerm
80 N643411f2882c405ca23a252140618781 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Stroke
82 rdf:type schema:DefinedTerm
83 N68ffadc509754cebb295d177aa0fd5c3 schema:affiliation https://www.grid.ac/institutes/grid.62560.37
84 schema:familyName Gonzalez Quesada
85 schema:givenName Carlos J.
86 rdf:type schema:Person
87 N69f4dc9c366444ccb1da5fbcddfb40b7 schema:name Springer Nature - SN SciGraph project
88 rdf:type schema:Organization
89 N8521bb898c30409f873825ea6bd5b605 rdf:first sg:person.0702207604.00
90 rdf:rest rdf:nil
91 Na89fa2ce93b54013952199b7d4bb94e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Gastrointestinal Hemorrhage
93 rdf:type schema:DefinedTerm
94 Nbe0bf36a322347c4b1edce7690bf5f48 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Atrial Fibrillation
96 rdf:type schema:DefinedTerm
97 Nbf0239847e7747c09341fbd250d02aa3 schema:name pubmed_id
98 schema:value 25416142
99 rdf:type schema:PropertyValue
100 Nc1ad978206424189be68cc9b0f1fa9c8 schema:name readcube_id
101 schema:value 0ed44acaa93949e127e802384aff805e1f8e1430dfd9050667cfd8e0e67b807d
102 rdf:type schema:PropertyValue
103 Nc6b6d081ee054abf8071ca5fc299bcd7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Anticoagulants
105 rdf:type schema:DefinedTerm
106 Ncb730f55db9a4e578517679cac6eae47 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Acute Coronary Syndrome
108 rdf:type schema:DefinedTerm
109 Nd77d384d66a14bf4b7bd8478d6b157e5 schema:name doi
110 schema:value 10.1007/s11239-014-1148-4
111 rdf:type schema:PropertyValue
112 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
113 schema:name Medical and Health Sciences
114 rdf:type schema:DefinedTerm
115 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
116 schema:name Cardiorespiratory Medicine and Haematology
117 rdf:type schema:DefinedTerm
118 sg:journal.1113719 schema:issn 0929-5305
119 1573-742X
120 schema:name Journal of Thrombosis and Thrombolysis
121 rdf:type schema:Periodical
122 sg:person.0702207604.00 schema:affiliation https://www.grid.ac/institutes/grid.62560.37
123 schema:familyName Giugliano
124 schema:givenName Robert P.
125 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702207604.00
126 rdf:type schema:Person
127 https://doi.org/10.1016/j.jacc.2014.03.022 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037324913
128 rdf:type schema:CreativeWork
129 https://doi.org/10.1016/s0140-6736(13)62343-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053051165
130 rdf:type schema:CreativeWork
131 https://doi.org/10.1056/nejmoa0905561 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018974880
132 rdf:type schema:CreativeWork
133 https://doi.org/10.1056/nejmoa1007432 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038815600
134 rdf:type schema:CreativeWork
135 https://doi.org/10.1056/nejmoa1009638 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051578846
136 rdf:type schema:CreativeWork
137 https://doi.org/10.1056/nejmoa1107039 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018510213
138 rdf:type schema:CreativeWork
139 https://doi.org/10.1056/nejmoa1310907 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023447903
140 rdf:type schema:CreativeWork
141 https://doi.org/10.1093/eurheartj/ehs253 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052629170
142 rdf:type schema:CreativeWork
143 https://doi.org/10.1093/europace/eut083 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011686963
144 rdf:type schema:CreativeWork
145 https://doi.org/10.7326/0003-4819-146-12-200706190-00007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073709095
146 rdf:type schema:CreativeWork
147 https://www.grid.ac/institutes/grid.62560.37 schema:alternateName Brigham and Women's Hospital
148 schema:name Department of Medicine, Brigham and Women’s Hospital, 75 Francis St, 02115, Boston, MA, USA
149 Division of Cardiovascular Medicine, TIMI Study Group, Brigham and Women’s Hospital, 350 Longwood Ave. 1st Floor Offices, 02115, Boston, MA, USA
150 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...